TITLE

Angiotensin II Type 1 Receptor Blocker Inhibits Pulmonary Injury

AUTHOR(S)
Mancini, G. B. John; Khalil, Nasreen
PUB. DATE
June 2005
SOURCE
Clinical & Investigative Medicine;Jun2005, Vol. 28 Issue 3, p118
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Pulmonary damage and fibrosis may be the result of diverse forms of injury and there is an association between pulmonary diseases and cardiovascular events. The purpose of this study was to evaluate the effects of an angiotensin II type I receptor blocker, valsartan, on systemic, cellular, and fibrotic consequences of pulmonary injury induced by the anti-neo- plastic antibiotic, bleomycin. Methods: Sprague Dawly rats were used in the classical bleomycin model of pulmonary fibrosis. Bleomycin (I unit, n = 7) was administered intra-tracheally to induce lung injury. Valsartan (0.66 mg) was given either concomitantly (n = 9) or for two days prior to bleomycin (n = 8). A control group (n = 6) was given normal saline. Results: Valsartan-treated animals showed abrogation of weight loss, suppression of release of total and active transforming growth factor beta-I (TGF-M), and diminished connective tissue synthesis. In an explant, lung tissue culture model devoid of alveolar macrophages (saline control, n = 3; bleomycin, n = 6; bleomycin plus valsartan, n = 12), both total and active TGF-&I were suppressed in the valsartan-treat- ed cohort. Conclusions: Valsartan, known to have cardio-protec- tive properties, was shown to be protective of bleomycin -induced pulmonary injury. Thus, ARBs may be beneficial in both cardiac and pulmonary diseases.
ACCESSION #
17764805

 

Related Articles

  • Pulmonary fibrosis: molecular mechanisms.  // Thorax;Dec2004 Supplement, Vol. 59, p41 

    The article presents abstracts of papers on the molecular mechanism of pulmonary fibrosis. One of the studies report on idiopathic pulmonary fibrosis, which is a progressive fibrotic lung disease that poses a therapeutic challenge because no treatment has a consistent impact on disease...

  • Effect of TGF-β/Smad signaling pathway on lung myofibroblast differentiation. Li Gu; Yuan-jue Zhu; Xiao Yang; Zi-Jian Guo; Wen-bing Xu; Xin-lun Tian // Acta Pharmacologica Sinica;Mar2007, Vol. 28 Issue 3, p382 

    Aim: Myofibroblasts play important roles in the pathogenesis of lung fibrosis. Transforming growth factor (TGF)-β1 has been widely recognized as a key fibrogenic cytokine. The major signaling pathway of TGF-β1 is through cytoplasmic Smad proteins. Our study investigated the role of...

  • Localisation of transforming growth factor β1 and β3 mRNA transcripts in normal and fibrotic human lung. Coker, R. K.; Laurent, G. J.; Jeffery, P. K.; du Bois, R. M.; Black, C. M.; McAnulty, R. J. // Thorax;Jul2001, Vol. 56 Issue 7, p549 

    Background--Transforming growth factor β1 is implicated in the pathogenesis of lung fibrosis. It promotes extracellular matrix accumulation by increasing procollagen synthesis and reducing degradation. TGFβ1 gene and protein expression increase in experimental lung fibrosis, and TGFβ1...

  • Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. BAOTIAN KAN; XIANGDONG JIAN; QIAN ZHOU; JIERU WANG; GUANGCAI YU; JING SUN; YIKAI GAO // Molecular Medicine Reports;2014, Vol. 9 Issue 4, p1232 

    In China, and other Asian countries, numerous patients have succumbed to pulmonary fibrosis induced by paquarat poisoning, but the early pathogenesis remains unclear. In this study the effect of cytokine transforming growth factor (TGF)-βl was observed in early acute paraquat poisoning and...

  • Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis. Yamada, Mizuho; Kuwano, Kazuyoshi; Maeyama, Takashige; Yoshimi, Michihiro; Hamada, Naoki; Fukumoto, Jutaro; Egashira, Kensuke; Hiasa, Kenichi; Takayama, Koichi; Nakanishi, Yoichi // Journal of Clinical Pathology;Aug2007, Vol. 60 Issue 8, p916 

    Background: Transforming growth factor-β1 (TGF-β1) has the potential to induce acute inflammation and apoptosis in lung epithelial cells and plays a central role in subsequent fibrosis. Aims: To examine a new anti-TGF-β1 therapy against lung injury and fibrosis, which comprises the...

  • High Throughput Determination of TGFβ1/SMAD3 Targets in A549 Lung Epithelial Cells. Zhang, Yingze; Handley, Daniel; Kaplan, Tommy; Yu, Haiying; Bais, Abha S.; Richards, Thomas; Pandit, Kusum V.; Zeng, Qilu; Benos, Panayiotis V.; Friedman, Nir; Eickelberg, Oliver; Kaminski, Naftali // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: Transforming growth factor beta 1 (TGFβ1) plays a major role in many lung diseases including lung cancer, pulmonary hypertension, and pulmonary fibrosis. TGFβ1 activates a signal transduction cascade that results in the transcriptional regulation of genes in the nucleus,...

  • Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils. Al-Muhsen, Saleh; Letuve, Severine; Vazquez-Tello, Alejandro; Pureza, Mary Angeline; Al-Jahdali, Hamdan; Bahammam, Ahmed S.; Hamid, Qutayba; Halwani, Rabih // Respiratory Research;Mar2013, Vol. 14 Issue 3, p1 

    Background: Subepithelial fibrosis is one of the most critical structural changes affecting bronchial airway function during asthma. Eosinophils have been shown to contribute to the production of pro-fibrotic cytokines, TGF-β and IL-11, however, the mechanism regulating this process is not...

  • Role of the myofibroblast in pulmonary fibrosis. PHAN, SEM H. // Kidney International Supplement;May1996, Issue 54, pS-46 

    The authors discuss the origination of myofibroblasts with alpha-smooth muscle actin phenotype that are found in pulmonary fibrosis. They mention that the myofibroblasts could be influenced by cytokines such as transforming growth factors-beta. Myofibroblasts may be the primary cause of...

  • Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts. Renzoni, Elisabetta A.; Abraham, David J.; Howat, Sarah; Xu Shi-Wen; Sestini, Piersante; Bou-Gharios, George; Wells, Athol U.; Veeraraghavan, Srihari; Nicholson, Andrew G.; Denton, Christopher P.; Leask, Andrew; Pearson, Jeremy D.; Black, Carol M.; Welsh, Kenneth I.; Du Bois, Roland M. // Respiratory Research;2004, Vol. 5, p24 

    Background: Transforming growth factor beta (TGFβ), a multifunctional cytokine, plays a crucial role in the accumulation of extracellular matrix components in lung fibrosis, where lung fibroblasts are considered to play a major role. Even though the effects of TGFβ on the gene expression...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics